PIPA5115729

PDE3A Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5115729-Each-of-1 In Stock ₹ 46,502.50

PIPA5115729 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

PDE3A

Classification

Polyclonal

Conjugate

Unconjugated

Gene

PDE3A

Gene Alias

A930022O17Rik; C87899; cAMP phosphodiesterase, myocardial cGMP-inhibited; CGI-PDE; CGI-PDE A; CGI-PDE-A; cGMP-inhibited 3',5'-cyclic phosphodiesterase A; cGMP-inhibited phosphodiesterase; cyclic GMP-inhibited phosphodiesterase A; cyclic nucleotide phosphodiesterase; HTNB; PDE3A; phosphodiesterase 3A; phosphodiesterase 3A, cGMP inhibited; phosphodiesterase 3A, cGMP-inhibited; RNPDE3A

Host Species

Rabbit

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

5139

Content And Storage

-20°C

Form

Liquid

Applications

Western Blot

Concentration

1 mg/mL

Formulation

PBS with 50% glycerol and 0.02% sodium azide

Gene Accession No.

Q14432

Gene Symbols

PDE3A

Immunogen

A synthesized peptide derived from human PDE3A(Accession Q14432), corresponding to amino acid residues K287-Q337.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human, Non-human Primate

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PA549996

--

Img

Thermo Scientific

PIMA525732

--

Img

Thermo Scientific

PIPA583938

--

Img

Novus Biologicals

NB262481

--

Img

Novus Biologicals

NB260729

--

Img

Thermo Scientific

PIPA5112864

--

Img

Novus Biologicals

NB322624

--

Img

Novus Biologicals

NB336136

--

Description

  • Antibody detects endogenous levels of total PDE3A
  • Cyclic nucleotide phosphodiesterases (PDEs) comprise a complex group of enzymes, and at least 5 major PDE families or classes with distinctive properties have been identified
  • Members of the cGMP-inhibited cAMP PDE (cGI-PDE) family, such as PDE3A, are characterized by high affinity for cAMP and cGMP and competitive inhibition of their cAMP hydrolytic activity by cGMP and certain positive inotropic agents (Meacci et al., 1992 [PubMed 1315035]).